苏州引入顶尖消化诊疗服务 沪苏两大医院共建国家临床医学研究分中心

Core Insights - Suzhou Municipal Hospital and the First Affiliated Hospital of Naval Medical University have signed an agreement to establish a National Clinical Research Center for Digestive System Diseases (Shanghai) branch, focusing on advanced medical technologies and research [1][2] Group 1: Clinical Research and Development - The Shanghai branch will emphasize standardized treatment of fecal microbiota transplantation (FMT), clinical research on inflammatory bowel disease, AI-assisted diagnosis, and robotic endoscopy technology [1] - The center will utilize over 300 beds at Suzhou Municipal Hospital's Taihu General Hospital, establishing specialized wards and a key laboratory for gut microbiome research [1][2] Group 2: Talent Development and Collaboration - The center aims to cultivate high-level clinical research teams through expert deployment, technical guidance, academic exchanges, and physician training [2] - Joint applications for national-level projects will be pursued to promote multi-center clinical research and enhance the quality of research outcomes [2] Group 3: Innovative Medical Approaches - FMT technology is highlighted as a treatment for refractory intestinal diseases and a new intervention approach for metabolic and neurodegenerative diseases [2] - The establishment of the Suzhou branch is seen as an opportunity to advance research and application of cutting-edge technologies like FMT, contributing to chronic disease management [2] Group 4: Academic Engagement - The third China Gut Microbiome and Fecal Microbiota Transplantation Academic Forum was held, gathering top experts to discuss cutting-edge research and clinical practices [2] - New expert consensus documents on gut microbiome testing and FMT clinical management were released, providing authoritative guidelines for nationwide clinical practices [2]